1887
Rapid communication Open Access
Like 0

Abstract

Whole genome sequencing data of 874 isolates carrying from 13 European Union/European Economic Area countries between 2012 and June 2022 showed the predominance of sequence types ST167, ST405, ST410, ST361 and ST648, and an increasing frequency of detection. Nearly a third (30.6%) of these isolates were associated with infections and more than half (58.2%) were predicted to be multidrug-resistant. Further spread of carrying would leave limited treatment options for serious infections.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2023.28.19.2300209
2023-05-11
2024-11-23
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2023.28.19.2300209
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/28/19/eurosurv-28-19-2.html?itemId=/content/10.2807/1560-7917.ES.2023.28.19.2300209&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level. Version 2.0. Stockholm: ECDC; 2018. Available from: https://ecdc.europa.eu/en/publications-data/ecdc-study-protocol-genomic-based-surveillance-carbapenem-resistant-andor
  2. Manges AR, Geum HM, Guo A, Edens TJ, Fibke CD, Pitout JDD. Global extraintestinal pathogenic Escherichia coli (ExPEC) lineages. Clin Microbiol Rev. 2019;32(3):e00135-18.  https://doi.org/10.1128/CMR.00135-18  PMID: 31189557 
  3. Zhou Z, Alikhan NF, Mohamed K, Fan Y, Agama Study Group, Achtman M. The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2020;30(1):138-52.  https://doi.org/10.1101/gr.251678.119  PMID: 31809257 
  4. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50(4):1355-61.  https://doi.org/10.1128/JCM.06094-11  PMID: 22238442 
  5. Peirano G, Chen L, Nobrega D, Finn TJ, Kreiswirth BN, DeVinney R, et al. Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015-2017. Emerg Infect Dis. 2022;28(5):924-31.  https://doi.org/10.3201/eid2805.212535  PMID: 35451367 
  6. Zankari E, Allesøe R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72(10):2764-8.  https://doi.org/10.1093/jac/dkx217  PMID: 29091202 
  7. Schürch AC, Arredondo-Alonso S, Willems RJL, Goering RV. Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene-based approaches. Clin Microbiol Infect. 2018;24(4):350-4.  https://doi.org/10.1016/j.cmi.2017.12.016  PMID: 29309930 
  8. Garcia-Fernandez A, Villa L, Bibbolino G, Bressan A, Trancassini M, Pietropaolo V, et al. Novel insights and features of the NDM-5-producing Escherichia coli sequence type 167 high-risk clone. MSphere. 2020;5(2):e00269-20.  https://doi.org/10.1128/mSphere.00269-20  PMID: 32350092 
  9. Barrado L, Pérez-Vázquez M, Del Pozo JL, Martín-Salas C, Leiva J, Mazón A, et al. Clonal transmission of NDM-5-producing Escherichia coli belonging to high-risk sequence type ST405. Int J Antimicrob Agents. 2018;52(1):123-4.  https://doi.org/10.1016/j.ijantimicag.2018.05.018  PMID: 29864499 
  10. Bibbolino G, Di Lella FM, Oliva A, Lichtner M, Del Borgo C, Raponi G, et al. Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019. Diagn Microbiol Infect Dis. 2021;100(4):115399.  https://doi.org/10.1016/j.diagmicrobio.2021.115399  PMID: 34030105 
  11. Roer L, Overballe-Petersen S, Hansen F, Schønning K, Wang M, Røder BL, et al. Escherichia coli sequence type 410 is causing new international high-risk clones. MSphere. 2018;3(4):e00337-18.  https://doi.org/10.1128/mSphere.00337-18  PMID: 30021879 
  12. Turton JF, Pike R, Perry C, Jenkins C, Turton JA, Meunier D, et al. Wide distribution of Escherichia coli carrying IncF plasmids containing blaNDM-5 and rmtB resistance genes from hospitalized patients in England. J Med Microbiol. 2022;71(8).  https://doi.org/10.1099/jmm.0.001569  PMID: 35925786 
  13. Hans JB, Pfennigwerth N, Neumann B, Pfeifer Y, Fischer MA, Eisfeld J, et al. Molecular surveillance reveals the emergence and dissemination of NDM-5-producing Escherichia coli high-risk clones in Germany, 2013 to 2019. Euro Surveill. 2023;28(10):2200509.  https://doi.org/10.2807/1560-7917.ES.2023.28.10.2200509  PMID: 36892470 
  14. Chakraborty T, Sadek M, Yao Y, Imirzalioglu C, Stephan R, Poirel L, et al. Cross-border emergence of Escherichia coli producing the carbapenemase NDM-5 in Switzerland and Germany. J Clin Microbiol. 2021;59(3):e02238-20.  https://doi.org/10.1128/JCM.02238-20  PMID: 33361340 
  15. Cummins EA, Snaith AE, McNally A, Hall RJ. The role of potentiating mutations in the evolution of pandemic Escherichia coli clones. Eur J Clin Microbiol Infect Dis. 2021.  https://doi.org/10.1007/s10096-021-04359-3  PMID: 34787747 
  16. Schaufler K, Semmler T, Wieler LH, Trott DJ, Pitout J, Peirano G, et al. Genomic and functional analysis of emerging virulent and multidrug-resistant Escherichia coli lineage sequence type 648. Antimicrob Agents Chemother. 2019;63(6):e00243-19.  https://doi.org/10.1128/AAC.00243-19  PMID: 30885899 
  17. Cox G, Ejim L, Stogios PJ, Koteva K, Bordeleau E, Evdokimova E, et al. Plazomicin retains antibiotic activity against most aminoglycoside modifying enzymes. ACS Infect Dis. 2018;4(6):980-7.  https://doi.org/10.1021/acsinfecdis.8b00001  PMID: 29634241 
  18. Bonnin RA, Emeraud C, Jousset AB, Naas T, Dortet L. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales. Clin Microbiol Infect. 2022;28(8):1156.e1-5.  https://doi.org/10.1016/j.cmi.2022.04.013  PMID: 35533970 
  19. Simner PJ, Mostafa HH, Bergman Y, Ante M, Tekle T, Adebayo A, et al. Progressive development of cefiderocol resistance in Escherichia coli during therapy is associated with an increase in blaNDM-5 copy number and gene expression. Clin Infect Dis. 2022;75(1):47-54.  https://doi.org/10.1093/cid/ciab888  PMID: 34618008 
  20. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual epidemiological report for 2021. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2021
/content/10.2807/1560-7917.ES.2023.28.19.2300209
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error